Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Corium to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Dicerna to Participate in Two Upcoming Investor Conferences
-
Axsome Therapeutics to Present at Upcoming Investor Conferences
-
Aerpio Pharmaceuticals to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
-
AxoGen, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
-
AxoGen, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Axsome Therapeutics to Present at Upcoming Investor Conferences
-
Protagonist Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference Monday, Oct. 1
-
Pfenex to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Ur-Energy (URG) Prices 12.2M Share Common Offering at $0.82/Sh
-
Ur-Energy Inc. Announces Pricing of Public Offering of Common Shares and Warrants
-
CareDx to Participate in Upcoming Investor Conference
-
Cantor Fitzgerald Starts Zynerba Pharmaceuticals (ZYNE) at Overweight
-
Supernus to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Supernus to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
ContraFect to Present at Two Upcoming Investor Conferences
-
aTyr Pharma to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
-
Ur-Energy (URG) Announces Proposed Common Share & Warrants Offering
-
Cantor Fitzgerald Starts Cara Therapeutics (CARA) at Overweight
-
Ur-Energy Inc. Announces Proposed Public Offering of Common Shares and Warrants
-
Cantor Fitzgerald Starts Kalvista Pharmaceuticals Inc (KALV) at Overweight
-
Cantor Fitzgerald Starts electroCore Inc. (ECOR) at Overweight
-
Cantor Fitzgerald Starts Cytokinetics (CYTK) at Overweight
-
Cantor Fitzgerald Starts Catalyst Pharmaceutical Partners (CPRX) at Overweight
-
Cantor Fitzgerald Starts Adverum Biotechnologies (ADVM) at Overweight
-
Matthew McConaughey, Common, Liev Schreiber And Dozens Of Stars Shine A Light On Charities, Raising Millions Of Dollars At BGC Partners', Cantor Fitzgerald's Charity Day
-
Alec Baldwin, Goldie Hawn, Common, And Dozens Of Other Stars Align To Raise Millions Of Dollars At Cantor Fitzgerald's And BGC Partners' Charity Day
-
Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences
-
Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences
-
PolarityTE to Participate in the 2018 Cantor Fitzgerald Global Healthcare Conference
-
UPDATE: Cantor Fitzgerald Starts HTG Molecular Diagnostics (HTGM) at Overweight
-
UPDATE: Cantor Fitzgerald Starts T2 Biosystems, Inc (TTOO) at Overweight
-
R1 RCM to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
-
Lantheus Holdings to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Aurinia to Participate in Upcoming Investor Conferences
-
Merit Medical to Present at Three Upcoming Conferences
-
Ovid Therapeutics to Present at Two Investor Healthcare Conferences in October 2018
-
Ovid Therapeutics to Present at Two Investor Healthcare Conferences in October 2018
-
Tactile Medical to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Foamix Announces Closing of its Follow-on Offering of Ordinary Shares and Full Exercise of its Option by the Underwriters
-
Achaogen to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Achaogen to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Evofem Biosciences to Present at Upcoming Investor Conferences
-
Verseon unveils new blockchain technology
-
WellCare Health Plans (WCG) PT Raised to $330 at Cantor Fitzgerald After Updating Numbers to Reflect Meridian Closing
-
VBL Therapeutics to Present at Upcoming Conferences in October
-
ProPhotonix Announces Deregistration of PPIR Line
-
Curetis To Attend Key Investor and Scientific Conferences In The Fourth Quarter 2018
-
Foamix (FOMX) Prices 11.67M Share Follow-On Offering at $6/Sh
-
Foamix Announces Pricing of its Follow-on Offering of Ordinary Shares


